Intriguingly, the findings of this paper revealed a previously unknown function of TL1A in NASH pathogenesis by regulating M1 macrophages polarization, and it may be a new therapeutic target for the treatment of NAFLD. Here, TNFSF15 is linked to metabolic dysfunction-associated steatotic liver disease.